ID: ALA4752621

Max Phase: Preclinical

Molecular Formula: C19H16N2O3S

Molecular Weight: 352.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(N2C(=O)CSC2c2ccc3cccc(O)c3n2)cc1

Standard InChI:  InChI=1S/C19H16N2O3S/c1-24-14-8-6-13(7-9-14)21-17(23)11-25-19(21)15-10-5-12-3-2-4-16(22)18(12)20-15/h2-10,19,22H,11H2,1H3

Standard InChI Key:  MTQUXKDZDDTRIK-UHFFFAOYSA-N

Associated Targets(Human)

Methionine aminopeptidase 1 614 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 352.42Molecular Weight (Monoisotopic): 352.0882AlogP: 3.73#Rotatable Bonds: 3
Polar Surface Area: 62.66Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.30CX Basic pKa: 3.46CX LogP: 3.11CX LogD: 3.10
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -0.66

References

1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA.  (2020)  Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1.,  186  [PMID:31759728] [10.1016/j.ejmech.2019.111860]

Source